~~<i id='DB1D17D988'><strike id='DB1D17D988'><tt id='DB1D17D988'><pre id='DB1D17D988'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

comprehensive

author：focus 2025-10-02 18:49:26 - browse：134

Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column.

Who we talked to:

Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Clinical trials giant ICON acquires HumanFirst

entertainment

Wikipedia

hotspot

Wikipedia

Adoctorflushesadonorkidneyduringatransplantprocedure.BRENDANSMIALOWSKI/AFP/GettyImagesAsIwasgettingr

WSS

Kenai launches with $82 million for Parkinson’s stem cell therapy

International team creates first chimeric human

As JPM 2024 winds down, some health tech firms project optimism

Biotech companies concerned about China biosecurity crackdown

Kenai launches with $82 million for Parkinson’s stem cell therapy

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

knowledge

comprehensive

entertainment

How to save PrEP access — and even expand it

In search for therapies for solid tumors, companies turn to claudin

Alkermes shareholders re

FDA does about

Dobbs anniversary: the lost opportunity of abortion as health care

Kenai launches with $82 million for Parkinson’s stem cell therapy

Dobbs anniversary: the lost opportunity of abortion as health care

A Q&A with Aletha Maybank, AMA’s chief health equity officer

United colonoscopy coverage change 'may cost lives,' doctors say

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Wikipedia

Idaho abortion case may prompt more restrictions in other states

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

An inside look at PIPEs, biotech's buzzy new financing tool

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

New menopause drug shows promise in relief for hot flashes

hotspot

hotspot

Wikipedia

Wikipedia